6-K
Alterity Therapeutics Ltd (ATHE)
SECURITIESAND EXCHANGE COMMISSION
Washington,D.C. 20549
FORM6-K
REPORTOF FOREIGN PRIVATE ISSUER
PURSUANTTO RULE 13a-16 OR 15d-163
UNDERTHE SECURITIES EXCHANGE ACT OF 1934
Forthe month of February 2025
AlterityTherapeutics Limited
(Name of Registrant)
Level 14, 350 Collins Street,Melbourne, Victoria 3000 Australia
(Address of Principal Executive Office)
Indicateby check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
ThisForm 6-K is being incorporated by reference into our Registration Statement on Form S-8 (Files No. 333-251073, 333-248980and 333-228671) and ourRegistration Statements on Form F-3 (Files No. 333-274816, 333-251647, 333-231417and 333-250076)
ALTERITYTHERAPEUTICS LIMITED
(adevelopment stage enterprise)
The following exhibits are submitted:
| 99.1 | Notice Under Section 708A & Application for quotation of securities |
|---|
1
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| Alterity Therapeutics Limited | |
|---|---|
| By: | /s/ Geoffrey P. Kempler |
| Geoffrey P. Kempler | |
| Chairman |
Date: February 4, 2025
2
Exhibit 99.1
| ASX ANNOUNCEMENT | 04 February 2025 |
|---|
Notice Under Section 708A(5)(e) of the CorporationsAct
This notice is given by Alterity Therapeutics Limited ACN 080 699 065 (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), under section 708A(5)(e) of the Corporations Act 2001 (Cth) (Corporations Act).
| Details of securities issued | |
|---|---|
| Type: | Shares |
| Class/Description: | Fully paid ordinary shares |
| ASX Code: | ATH |
| Date of Issue: | 03 February 2025 |
| Number Issued: | 164,242,200 |
The Company gives notice pursuant to section 708A(5)(e) of the Corporations Act that:
| 1. | the Company issued the Shares without disclosure under Part 6D.2 of the Corporations Act; |
|---|---|
| 2. | as at the date of this notice, the Company has complied with: |
| --- | --- |
| (i) | the provisions of Chapter 2M of the Corporations Act as they apply to the Company; and |
| --- | --- |
| (ii) | sections 674 and 674A of the Corporations Act; and |
| --- | --- |
| 3. | as at the date of this notice there is no information to be disclosed which is ‘excluded information’<br>(as defined in sections 708A(7) and 708A(8) of the Corporations Act) which is required to be disclosed by the Company. |
| --- | --- |
| /s/ Abby Macnish Niven | |
| --- | |
| Abby Macnish Niven | |
| Company Secretary |
Alterity Therapeutics Limited ACN 080 699 065
Level 14, 350 Collins Street, Melbourne, Victoria 3000 Australia
www.alteritytherapeutics.com
| Appendix 2A - Application for quotation of securities |
|---|
Announcement Summary
Entity name
ALTERITY THERAPEUTICS LIMITED
Announcement Type
New announcement
Date of this announcement
Tuesday February 04, 2025
The+securities to be quoted are:
+Securities issued as part of a transaction or transactions previously announced to the market in an Appendix 3B
Total number of +securities to be quoted
| ASX +security code | Security description | Number of +securities to be quoted | Issue date |
|---|---|---|---|
| ATH | ORDINARY FULLY PAID | 164,242,200 | 03/02/2025 |
Refer to next page for full details of the announcement
| Appendix 2A - Application for quotation of securities | 1 / 6 |
|---|---|
| Appendix 2A - Application for quotation of securities | |
| --- |
Part 1 - Entity and announcement details
1.1Name of entity
ALTERITY THERAPEUTICS LIMITED
We (the entity named above) apply for +quotation of the following +securities and agree to the matters set out in Appendix 2A of the ASX Listing Rules.
| 1.2 Registered number type | Registration number |
|---|---|
| ABN | 37080699065 |
1.3ASX issuer code
ATH
1.4The announcement is
New announcement
1.5Date of this announcement
4/2/2025
| Appendix 2A - Application for quotation of securities | 2 / 6 |
|---|---|
| Appendix 2A - Application for quotation of securities | |
| --- |
Part 2 - Type of Issue
2.1 The+securities to be quoted are:
+Securities issued as part of a transaction or transactions previously announced to the market in an Appendix 3B
Previous Appendix 3B details:
| Announcement Date and Time | Announcement Title | Selected Appendix 3B to submit quotation request |
|---|---|---|
| 03-Feb-2025 09:58 | New - Proposed issue of securities - ATH | A placement or other type of issue |
2.3a.2 Are there any further issues of +securities yet to take place to complete the transaction(s) referred to in the Appendix 3B?
No
| Appendix 2A - Application for quotation of securities | 3 / 6 |
|---|---|
| Appendix 2A - Application for quotation of securities | |
| --- |
Part 3A - number and type of +securities to be quoted where issue has previously been notified to ASX in an Appendix 3B
Placement Details
ASX +security code and description
ATH : ORDINARY FULLY PAID
Issue date
3/2/2025
Distribution Schedule
Provide a distribution schedule for the new +securitiesaccording to the categories set out in the left hand column - including the number of recipients and the total percentage of the new+securities held by the recipients in each category.
| Total percentage of +securities held | ||
|---|---|---|
| Number of +securities held | Number of holders | For example, to enter a value of 50% please input as 50.00 |
| 1 - 1,000 | % | |
| 1,001 - 5,000 | % | |
| 5,001 - 10,000 | % | |
| 10,001 - 100,000 | % | |
| 100,001 and over | % |
| Appendix 2A - Application for quotation of securities | 4 / 6 |
|---|---|
| Appendix 2A - Application for quotation of securities | |
| --- |
Issue details
Number of +securities to be quoted
164,242,200
Are the +securities being issued for a cash consideration?
Yes
| In what currency is the cash consideration being paid? | What is the issue price per +security? |
|---|---|
| AUD - Australian Dollar | AUD 0.01290000 |
Any otherinformation the entity wishes to provide about the +securities to be quoted
| Appendix 2A - Application for quotation of securities | 5 / 6 |
|---|---|
| Appendix 2A - Application for quotation of securities | |
| --- |
Part 4 - Issued capital following quotation
Following thequotation of the +securities the subject of this application, the issued capital of the entity will comprise:
The figures in parts 4.1 and 4.2 below are automatically generated and may not reflect the entity’s current issued capital if other Appendix 2A, Appendix 3G or Appendix 3H forms are currently with ASX for processing.
4.1 Quoted+securities (total number of each +class of +securities quoted on ASX following the +quotation of the +securities subject of thisapplication)
| ASX +security code and description | Total number of +securities on issue | |
|---|---|---|
| ATH : ORDINARY FULLY PAID | 5,491,006,889 | |
| ATHO : OPTION EXPIRING 31-AUG-2026 | 932,611,430 |
4.2 Unquoted+securities (Total number of each +class of +securities issued but not quoted on ASX)
| ASX +security code and description | |
|---|---|
| ATHAAE : OPTION EXPIRING 29-NOV-2026 EX 0.0375 | 14,250,000 |
| ATHAAG : OPTION EXPIRING 29-NOV-2026 EX 0.0238 | 11,900,000 |
| ATHAAB : OPTION EXPIRING 17-SEP-2025 EX 0.09 | 35,000,000 |
| ATHAAK : OPTION EXPIRING 30-DEC-2027 EX 0.01 | 170,000,000 |
| ATHAAH : OPTION EXPIRING 19-DEC-2026 EX 0.0105 | 8,000,000 |
| ATHAB : OPTION EXPIRING 13-MAR-2029 EX US0.0031 | 62,500,000 |
| ATHAA : OPTION EXPIRING 13-MAR-2029 EX 0.004 | 20,166,667 |
| ATHAC : OPTION EXPIRING 21-MAR-2029 EX US0.003 | 120,000,000 |
| ATHAAD : OPTION EXPIRING 06-JAN-2026 EX 0.032 | 91,392,720 |
All values are in US Dollars.
| Appendix 2A - Application for quotation of securities | 6 / 6 |
|---|